Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description adds substantial behavioral context beyond the annotations: it discloses cascading internal lookups, graceful degradation when GLEIF or OpenFIGI is unavailable, explicit handling of unresolved identifiers via an `unresolved` field, behavior when a name maps to multiple instruments (`figi_candidates`), and source labeling for each identifier. This is far beyond the readOnly/openWorld/idempotent hints already present.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with the use case and 'Use FIRST' guidance, which is ideal. It is long and dense, but most sentences earn their place given the tool's complexity and the lack of an output schema. A few parenthetical asides add length without much new information, so it is not maximally concise.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a two-parameter tool with no output schema, the description is remarkably complete. It covers supported types, accepted input formats, edge cases (ambiguous matches, non-equity securities, unavailable external sources), and expected behavior around unresolved identifiers. An agent has enough context to know when this tool applies and what it will return in tricky situations.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The schema already covers both parameters thoroughly, so the baseline is 3. The description adds meaningful extra semantics: it introduces ISIN as an accepted input not listed in the schema, explains the distinction between exact ticker mapping and name search, and provides a concrete negative example ('NEW YORK ST DORM AUTH revenue bonds') to clarify what should not be passed in `value`. This exceeds what the schema alone provides.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a clear, specific purpose: resolving a user-spoken name or identifier into canonical/official identifiers required by other tools. It lists concrete example queries, supported entity types (company, drug), and distinguishes itself from sibling tools like entity_profile by framing it as the first step when an ID is needed.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly says to use this tool 'FIRST whenever you have a name but need an ID,' which is strong usage guidance. It also enumerates accepted input forms (ticker, CIK, ISIN, company name, brand/generic drug name) and supported entity types. However, it does not explicitly mention when not to use it or name specific alternatives, so it falls just short of a 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4.3/5.0
Disambiguation5/5

Each tool has a clearly distinct purpose, from querying data (ask_pipeworx) to entity profiling (entity_profile) to prediction market analysis (polymarket_arbitrage, polymarket_edges). Even similar tools like deep_research and ask_pipeworx are differentiated by scope (single vs. multi-facet). There is no ambiguity.

Naming Consistency4/5

The vast majority of tools use snake_case (e.g., validate_claim, compare_entities). However, a few tools are single words (forget, recall, remember, subscribe, unsubscribe) which breaks the pattern slightly. This is a minor inconsistency.

Tool Count4/5

With 33 tools, the set is on the larger side but well-justified by the broad scope of the server (data querying, entity research, prediction markets, JSON utilities, subscriptions, etc.). Each tool serves a specific need, making the count appropriate.

Completeness5/5

The tool surface covers virtually all expected operations for the domain: querying, profiling, comparison, change tracking, validation, discovery, subscriptions, memory, and utilities. No obvious gaps are present for the intended use case of accessing Pipeworx data and related tasks.